FindTrial
Sign In

Comparison of homoeopathic medicine PANCREATINUM 30 C & INSULINUM 30 C in Diabetes patients aged 30-75 years

Comparative study of Pancreatinum 30 c & Insulinum 30 c in DM type II patients aged 30 to 75 years A randomized control trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086814
Enrollment
40
Registered
2025-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: INSULINUM 30C: INSULINUM 30C 4 globules of 40 no. size BD before meals for 15 days Control Intervention1: PANCREATINUM 30 C: Pancreatinum 30 C 4 globules of 40 no size BD before meals

Sponsors

Maharashtra University of Health Science Nashik
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients of diagnosed cases of Diabetes Mellitus Type-2 with or without complications . 2 Patients taking tablet Metamorphic orally for at least 3 months 3 Patients having fasting NSL above 130mg/dl and PP above 200mg/dl for at least 2 months

Exclusion criteria

Exclusion criteria: 1 Immunosuppressive patients. 2 Pregnant females 3 Patients taking subcutaneous injection of Insulin for Diabetes Mellitus Type-2.

Design outcomes

Primary

MeasureTime frame
Change in Blood Glucose Level if anyTimepoint: Change in Blood Glucose Level if any is assessed at baseline every monthly for 3 months—

Secondary

MeasureTime frame
NilTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Padamavati Abhijit Kumbhar

Late Mrs Housabai Homoeopathic Medical College and Hospital Nimshirgaon

khushimehta11.km@gmail.com8928612795

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026